Drug
brodalumab
Marketed as SILIQ.
Generic name
brodalumab
Brand names
SILIQ
First FDA approval
2017-02-15
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761032 | SILIQ | 2017-02-15 | VALEANT LUXEMBOURG |
Manufacturers
VALEANT LUXEMBOURG
Frequently asked questions
When was brodalumab FDA approved?
Earliest FDA approval on record: 2017-02-15.
What brand names are sold as brodalumab?
SILIQ.
Sources
Appeal a brodalumab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com